---
created: 2025-04-13
updated: 2025-04-13T10:52
id: lHwTvQ?a=5
specialty: pharmaco
specialty_id: 261
tags:
  - source/ak-original-decks::step-1::zanki-pharmacology
  - "source/ak-step1-v11:": 
  - theme/b&b::11-hematology::01-hemostasis::06-antiplatelet-drugs
  - "source/ak-step1-v11:": 
  - theme/b&b::11-hematology::01-hemostasis::07-anticoagulants
  - "source/ak-step1-v11:": 
  - theme/firstaid::05-pharmacology::02-autonomic-drugs::15-phosphodiesterase-inhibitors
  - "source/ak-step1-v11:": 
  - theme/firstaid::05-pharmacology::02-autonomic-drugs::15-phosphodiesterase-inhibitors::pde-3-inhibitors
  - "source/ak-step1-v11:": 
  - theme/firstaid::05-pharmacology::02-autonomic-drugs::15-phosphodiesterase-inhibitors::pde-3-inhibitors::antiplatelet-agents
  - "source/ak-step1-v11:": 
  - theme/firstaid::10-hematology-oncology::05-pharm::08-pde-inhibitors
  - "source/ak-step1-v11:": 
  - theme/nbme::20
  - "source/ak-step1-v11:": 
  - theme/nbme::27
  - "source/ak-step1-v11:": 
  - source/ome-banner::basic-science::13-hematology-oncology::11-hemostasis
  - "source/ak-step1-v11:": 
  - theme/physeo::09-pharm::17-hem/onc-pharm::antiplatelet-inhibitors
  - "source/ak-step1-v11:": 
  - theme/pixorize::03-pharm::10-heme::pde3-inhibitors-(cilostazol,-dipyridamole)
  - "source/ak-step1-v11:": 
  - theme/sketchypharm::03-blood-&-inflammation::01-anticoagulants-&-thrombolytics::03-antiplatelet-agents
  - "source/ak-step1-v11:": 
  - theme/uworld::1000-9999::1000-1999::1080
  - source/ak-step1-v11::^other::^highyield::1-highyield
  - "source/ak-step2-v11:": 
  - theme/amboss
  - "source/ak-step2-v11:": 
  - theme/amboss::im"
type: flashcard
---

# Question
Can PDE inhibitors reduce symptoms of claudication in peripheral artery disease?    **Yes (e.g. cilostazol)**

---

# Answer
